Top Markets
Coin of the day
BELLUS Health Inc. BELLUS Health Inc.

BELLUS Health Inc.

BLU
Classement en actions #6896
BELLUS Health Inc. is a biopharmaceutical firm in the clinical development... BELLUS Health Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to creating new therapeutic options for intractable chronic cough (RCC) and various other conditions characterized by heightened cough sensitivity. The company's primary investigational compound, BLU-5937, functions as a P2X3 receptor antagonist. This drug is currently progressing through Phase II clinical trials, where it is being assessed for its potential in treating both RCC and persistent itching. Founded in 1993, BELLUS Health Inc. is headquartered in Laval, Canada.
Prix de l'action
$14.30
Dernière synchronisation: 2023-06-29
Capitalisation boursière
$1.81B
Changement (1 jour)
-2.81%
Changement (1 an)
0.00%
Pays
CA
Échange BELLUS Health Inc. (BLU)

Catégorie

Historique du prix de l'action pour BELLUS Health Inc. (BLU)
Prix de clôture le plus élevé : $14.62 le 2023-06-01

Prix de clôture le plus bas : $617.12 le 2000-06-01
Historique du prix de l'action de BELLUS Health Inc. de 2000 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 56.80%
2022 31.13%
2021 132.06%
2020 -56.49%
2019 141.94%
2018 161.76%
2017 54.42%
2016 -72.16%
2015 -39.98%
2014 212.05%
2013 -6.93%
2012 -69.52%
2011 -61.15%
2010 -32.03%
2009 -57.70%
2008 -83.40%
2007 -89.98%
2006 82.43%
2005 -27.25%
2004 -7.64%
2003 313.71%
2002 87.44%
2001 -57.20%
2000 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$548.36 39.87%
US
$1.06K 50.29%
NL
$121.16 -12.75%
AU
$140.81 475.44%
US
$765.25 7.74%
CH